Search results for: Consulting Reports
Filter search results
Virtual ISPOR European 2020
10 November 2020
…Assessment of Histology Independent Therapies Lotte Steuten, PhD, MSc Vice President and Head of Consulting, Office of Health Economics Moderator Lotte will moderate this Educational Symposium where panellists will provide…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…Henderson N., Steuten L., 2020. Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Medicines. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/bridging-gap-pathways-regulatory-and-health-technology-assessment-histology-independent…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
…and Bruce, A., 2021. Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/why-we-need-new-outcomes-bas https://www.ohe.org/publications/why-we-need-new-outcomes-based-value-attribution-framework-combination-regimens…
Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?
29 April 2021
…to Estimate Cost-effectiveness Thresholds for Decision Making. [OHE Consulting Report] Office of Health Economics. Available at: https://www.ohe.org/publications/shaping-research-agenda-estimate-cost-effectiveness-thresholds-decision-making [Accessed 28 Apr. 2021]. Karlsberg Schaffer, S., Sussex, J., Devlin, N. and Walker,…
Rare Disease Day 2022
28 February 2022
…discussed in an OHE Consulting Report, particularly in the context of NICE’s appraisal of rare and ultra-rare conditions. We also considered to what extent standard appraisal processes are appropriate for…
OHE Welcomes Patrick Holmes to the Board of Trustees
28 March 2022
…and Associations (EFPIA) Healthcare Systems Working Group. Further, as OHE continues to develop a portfolio of research and consulting in the US policy arena Patrick’s experience with the US health…
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
…these barriers, which were developed through an expert roundtable project, sponsored by Pfizer, soon to be published as an OHE Consulting Report. Louis Garrison (Professor Emeritus at the CHOICE Institute,…
The Benefits of Early Engagement with Payers and Patient Representatives: The Case Study of a MoCA Pilot Project on ANCA-associated Vasculitis
30 June 2022
…value of a novel orphan medicine. Related research Towse, A. and Garau, M. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc Garau,…
Medical Manpower
7 January 1966
…disease, consulting a random physician, had a better than fifty-fifty chance of benefiting from the encounter’. Medical progress since then, and especially in the last two decades, has been more…